Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

22
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
22
Hormonal Regulation01:33

Hormonal Regulation

33.4K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

701
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
701
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

704
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
704
Introduction to Urinary System01:13

Introduction to Urinary System

3.3K
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
3.3K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antimicrobial susceptibility, molecular characterization and multilocus sequence typing of Staphylococcus aureus isolates associated with subclinical mastitis in buffaloes (Bubalus bubalis) in Haryana, India.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2026
Same author

Balancing Relief and Risk: Managing Chronic Low Back Pain in Patients with Opioid Use Disorder.

Southern medical journal·2026
Same author

Autoinfarction of the Parathyroid Gland: An Unusual Presentation of Primary Hyperparathyroidism.

Case reports in endocrinology·2026
Same author

Assessment of Total Delays and Their Associated Factors among Breast, Cervical, and Head and Neck Cancers in Northwestern India: A Cross-Sectional Study.

Asian Pacific journal of cancer prevention : APJCP·2026
Same author

A Qualitative Study of the Lived Experiences and Needs of Parent Caregivers of People With Cystic Fibrosis.

Pediatric pulmonology·2026
Same author

Understanding antimicrobial resistance phenotype in Indian clinical isolates through genomic lens.

Biochemical and biophysical research communications·2026

Related Experiment Video

Updated: Jul 26, 2025

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

17.9K

Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States.

Ashok Kumar Kanugula1, Jasleen Kaur2, Jaskaran Batra3

  • 1Department of Internal Medicine, Wellstar Health System - Spalding Regional Hospital, Griffin, USA.

Cureus
|June 23, 2023
PubMed
Summary

The renin-angiotensin system (RAS) regulates blood pressure and fluid balance. Newer discoveries reveal protective pathways and roles in obesity, offering novel therapeutic targets for cardiorenal and metabolic disorders.

Keywords:
cardio-protectioncardiovascularhypertensionobesityrenin-angiotensin-aldosterone system

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.9K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.3K

Related Experiment Videos

Last Updated: Jul 26, 2025

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

17.9K
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.9K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.3K

Area of Science:

  • Physiology
  • Endocrinology
  • Pharmacology

Background:

  • The renin-angiotensin system (RAS) is traditionally known for blood pressure regulation and fluid homeostasis.
  • Dysfunction of the classical RAS pathway contributes to cardiac and renal diseases.
  • Recent discoveries have unveiled new peptides and a counter-regulatory pathway within the RAS.

Purpose of the Study:

  • To provide an updated overview of the renin-angiotensin system.
  • To discuss the RAS's role in physiological and pathological processes.
  • To explore novel therapeutic targets within the RAS for various disorders.

Main Methods:

  • Literature review of classical and contemporary RAS research.
  • Analysis of physiological and pathological roles of RAS components.
  • Identification of emerging therapeutic strategies targeting the RAS.

Main Results:

  • The RAS is a complex system with both classical and counter-regulatory pathways.
  • RAS components are implicated in cardiorenal disorders, obesity, and metabolic diseases.
  • Newer molecules within the RAS present promising therapeutic targets.

Conclusions:

  • The understanding of the RAS has evolved beyond its classical role.
  • Targeting novel RAS components offers potential for managing cardiorenal and metabolic diseases.
  • Further research into the RAS is crucial for developing improved therapeutic interventions.